Zobrazeno 1 - 10
of 274
pro vyhledávání: '"G Morstyn"'
Publikováno v:
Blood. 88:1907-1929
T HAS BEEN KNOWN for at least three decades that very specific factors control hematopoiesis, acting on early cells in the hematopoietic system to produce mature, functional cells. The isolation, purification, and cloning of these factors has lead to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077d6a917afc5889fc04f99a6e757e75
https://doi.org/10.1182/blood.v88.6.1907.bloodjournal8861907
https://doi.org/10.1182/blood.v88.6.1907.bloodjournal8861907
Publikováno v:
Ciba Foundation symposium. 204
Recombinant human granulocyte colony-stimulating factor (rHuG-CSF) has been shown to stimulate the production and function of neutrophils in vitro and in vivo. Clinical studies in patients receiving myelosuppressive chemotherapy showed earlier neutro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::644af5eb73f93d77e0126e50b1939217
https://pubmed.ncbi.nlm.nih.gov/9107412
https://pubmed.ncbi.nlm.nih.gov/9107412
Publikováno v:
Cancer chemotherapy and biological response modifiers. 16
Hematopoietic growth factors have made a significant impact on the treatment of cancer, primarily in the prevention of infections associated with chemotherapy-induced neutropenia, in progenitor cell transplantation, in chemotherapy-induced thrombocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2bb2c8528c9428573e4488d76b609d9f
https://pubmed.ncbi.nlm.nih.gov/8639388
https://pubmed.ncbi.nlm.nih.gov/8639388
Publikováno v:
Radiation research. 137(3)
Cytokines that stimulate growth and differentiation of hematopoietic precursor cells have been used as protectors in vivo against ionizing radiation. Recently, we have shown that the nitroxide tempol is also an effective radiation protector in vivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1c8e8bfae4446d2171876e836dbf0189
https://pubmed.ncbi.nlm.nih.gov/7511822
https://pubmed.ncbi.nlm.nih.gov/7511822
Autor:
G, Morstyn, G J, Lieschke
Publikováno v:
Cancer chemotherapy and biological response modifiers. 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17db19343367898601d9a4c21e67b563
https://pubmed.ncbi.nlm.nih.gov/7540031
https://pubmed.ncbi.nlm.nih.gov/7540031
Autor:
A, Grigg, C G, Begley, C A, Juttner, J, Szer, L B, To, D, Maher, K M, McGrath, G, Morstyn, R M, Fox, W P, Sheridan
Publikováno v:
Bone marrow transplantation. 11
The haematopoietic growth factor (HGF), granulocyte colony stimulating factor (G-CSF; filgrastim) substantially shortens the period of severe neutropenia that follows high-dose chemotherapy and autologous bone marrow infusion by stimulating granulopo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b9244f3ee42ecec281989cc1720a5f1
https://pubmed.ncbi.nlm.nih.gov/8334435
https://pubmed.ncbi.nlm.nih.gov/8334435
Autor:
G, Morstyn, W P, Sheridan
Publikováno v:
Cancer chemotherapy and biological response modifiers. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0767e217ef353dcff1972dd51aff23b4
https://pubmed.ncbi.nlm.nih.gov/8312108
https://pubmed.ncbi.nlm.nih.gov/8312108
Autor:
D, Raghavan, J F, Bishop, R, Stuart-Harris, J, Zalcberg, G, Morstyn, R F, Kefford, J P, Matthews
Publikováno v:
Seminars in oncology. 19(1 Suppl 2)
The efficacy and toxicity of two regimens based on etoposide/carboplatin with or without cyclophosphamide/vincristine in the management of small cell lung cancer (SCLC) were assessed by the Australian Lung Cancer Study Group. Response rates of 77% an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d2df45c8eaa1e92ab25f3adb0826bc41
https://pubmed.ncbi.nlm.nih.gov/1329217
https://pubmed.ncbi.nlm.nih.gov/1329217
Autor:
G. Morstyn
Publikováno v:
Cytokines in Hemopoiesis, Oncology, and AIDS II ISBN: 9783540552420
High-dose chemotherapy with autologous bone marrow transplantation (ABMT) is increasingly being used as salvage therapy for patients with relapsed or refractory malignancies [1, 2]. There is an accumulating amount of clinical data to show that in sel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2573fef9963dafc2b9c84d59790146d7
https://doi.org/10.1007/978-3-642-48715-6_60
https://doi.org/10.1007/978-3-642-48715-6_60
Publikováno v:
Cytokines in Hemopoiesis, Oncology, and AIDS II ISBN: 9783540552420
The production of blood cells is known to be under the control of up to 20 different cytokines [1]. In recent years many of the cytokines have been identified and cloned, and are now in clinical trials. Several of the cytokines, including interleukin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d69638968451922e3dd9913c91a59dbc
https://doi.org/10.1007/978-3-642-48715-6_2
https://doi.org/10.1007/978-3-642-48715-6_2